138 related articles for article (PubMed ID: 20480727)
1. Melatonin and elimination of kynurenines in children with Down's syndrome.
Uberos J; Romero J; Molina-Carballo A; Muñoz-Hoyos A
J Pediatr Endocrinol Metab; 2010 Mar; 23(3):277-82. PubMed ID: 20480727
[TBL] [Abstract][Full Text] [Related]
2. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures.
Muñóz-Hoyos A; Molina-Carballo A; Rodríguez-Cabezas T; Uberos-Fernández J; Ruiz-Cosano C; Acuña-Castroviejo D
Clin Endocrinol (Oxf); 1997 Dec; 47(6):667-77. PubMed ID: 9497873
[TBL] [Abstract][Full Text] [Related]
3. Comparison between tryptophan methoxyindole and kynurenine metabolic pathways in normal and preterm neonates and in neonates with acute fetal distress.
Muñoz-Hoyos A; Molina-Carballo A; Macías M; Rodríguez-Cabezas T; Martín-Medina E; Narbona-López E; Valenzuela-Ruiz A; Acuña-Castroviejo D
Eur J Endocrinol; 1998 Jul; 139(1):89-95. PubMed ID: 9703384
[TBL] [Abstract][Full Text] [Related]
4. Relationship between tryptophan intake and urinary excretion of 3-hydroxy-kynurenine, 3-hydroxyanthranilic acid, xanthurenic acid and kynurenic acid.
Watanabe M; Takahashi T; Yoshida M; Suzuki M; Muramatsu S
J Nutr Sci Vitaminol (Tokyo); 1979; 25(2):115-22. PubMed ID: 479960
[No Abstract] [Full Text] [Related]
5. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
Nayak BN; Buttar HS
J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of tryptophan metabolism (kynurenine pathway) found in a group of 830 mentally retarded children.
Sabater J; Ricós C
Clin Chim Acta; 1974 Oct; 56(2):175-86. PubMed ID: 4434630
[No Abstract] [Full Text] [Related]
7. Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2
Forrest CM; Kennedy PG; Rodgers J; Dalton RN; Turner C; Darlington LG; Cobb SR; Stone TW
Neurochem Int; 2016 Nov; 100():110-119. PubMed ID: 27623092
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
Forrest CM; Mackay GM; Oxford L; Stoy N; Stone TW; Darlington LG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1078-87. PubMed ID: 17042918
[TBL] [Abstract][Full Text] [Related]
9. A new aspect of the urinary excretion of tryptophan metabolites in patients with cancer of the bladder.
Teulings FA; Peters HA; Hop WC; Fokkens W; Haije WG; Portengen H; van der Werf-Messing B
Int J Cancer; 1978 Feb; 21(2):140-6. PubMed ID: 627424
[No Abstract] [Full Text] [Related]
10. Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects.
Reiter RJ; Barlow-Walden L; Poeggeler B; Heiden SM; Clayton RJ
J Pineal Res; 1996 Jan; 20(1):45-50. PubMed ID: 8648562
[TBL] [Abstract][Full Text] [Related]
11. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of tryptophan metabolites during phototherapy.
Rubaltelli FF; Allegri G; Costa C; De Antoni A
J Pediatr; 1974 Dec; 85(6):865-7. PubMed ID: 4417880
[No Abstract] [Full Text] [Related]
13. The functional capacity of the tryptophan-niacin pathway in pellagrous children.
Abdel-Daim MH; Kholief TS; Konbar AA; Abdel-Tawab GA
Trans R Soc Trop Med Hyg; 1970; 64(3):454-9. PubMed ID: 5453504
[No Abstract] [Full Text] [Related]
14. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.
Bortolotti P; Hennart B; Thieffry C; Jausions G; Faure E; Grandjean T; Thepaut M; Dessein R; Allorge D; Guery BP; Faure K; Kipnis E; Toussaint B; Le Gouellec A
BMC Microbiol; 2016 Jul; 16(1):137. PubMed ID: 27392067
[TBL] [Abstract][Full Text] [Related]
15. [Studies on tryptophan metabolism in untreated phenylketonuric patients].
Kochen W; Byrd DJ; Bühner R; Bühlen E
Z Klin Chem Klin Biochem; 1975 Jan; 13(1):1-12. PubMed ID: 123676
[TBL] [Abstract][Full Text] [Related]
16. Urine composition in the etiology of bladder tumor formation.
Schlegel JU; Pipkin G; Banowsky L
J Urol; 1967 Mar; 97(3):479-81. PubMed ID: 6019608
[No Abstract] [Full Text] [Related]
17. The effect of environment on tryptophan metabolism "via kynurenine" in oral contraceptives users.
El-Zoghby ; El-Kholy ZA; Saad AA; Mostafa MH; Abdel-Tawab GA; El-Dardiri N; El-Kabariti H; Abdel-Rafea A
Acta Vitaminol Enzymol; 1978; 32(5-6):167-75. PubMed ID: 583198
[TBL] [Abstract][Full Text] [Related]
18. The degradation of tryptophan during paper chromatography with observations on some metabolites of tryptophan.
Lipton R; Price TD; Melicow MM
J Chromatogr; 1967 Feb; 26(2):412-23. PubMed ID: 6032152
[No Abstract] [Full Text] [Related]
19. [Studies on the L-tryptophan metabolism in children with Down's syndrome].
Vassella F; Colombo JP; Gloor RD; Rossi E
Helv Paediatr Acta; 1968 Aug; 23(4):419-28. PubMed ID: 4234242
[No Abstract] [Full Text] [Related]
20. Potentiation of endotoxin shock by oral L-tryptophan.
Boruchow IB; Ludwig GD; Wontorsky D
Am J Physiol; 1968 Mar; 214(3):525-31. PubMed ID: 5638984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
